SCHEMBL17367157

SCHEMBL17367157

c1ccc(-n2c3ccccc3c3c4ccccc4c4c(sc5sc6ccccc6c54)c32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HSD17B10 Q99714 1/20 0.38
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
ALDH1A1 P00352 3/20 0.35
GAA P10253 2/20 0.35
PDE1B Q01064 1/20 0.32
PDE3A Q14432 1/20 0.32
PDE11A Q9HCR9 1/20 0.32
MAPK8 P45983 2/20 0.31
GPR3 P46089 1/20 0.31
IL1R1 P14778 1/20 0.31
HTT P42858 2/20 0.30
KDR P35968 1/20 0.30
PAX8 Q06710 1/20 0.30
SIGMAR1 Q99720 1/20 0.30
MAPT P10636 2/20 0.30
MAPK9 P45984 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17246572 0.89 ATM (0.46) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL19985927 0.87 ATM (0.44) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL16606411 0.87 ATM (0.44) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL17405699 0.86 ATM (0.46) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL17405816 0.86 ATM (0.46) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL17405408 0.86 ATM (0.46) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL18748700 0.84 KDM4E (0.39) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL17405504 0.84 ATM (0.47) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL18688035 0.83 ATM (0.43) ATML3MBTL1KDM4EHSD17B10KMT2A
SCHEMBL17367120 0.82 ATM (0.46) ATML3MBTL1KDM4EHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-18 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, CRY1, CYP1B1 ATM 3202/4885L3MBTL1 717/4885KDM4E 3404/4885
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same CYP1A1, CRY1, CYP1B1 ATM 3202/4885L3MBTL1 717/4885KDM4E 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.